HCPCS Level IIdrugActive
J2260
Inj milrinone lactate / 5 mg
BETOS: O1E
Effective: 2018-01-01
Referenced in 2 policies
Description
Injection, milrinone lactate, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Milrinone Lactate
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
5 MG
Billing Units
4.0000
32
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.